algorithm safety

NEW YORK, N.Y., May 20, 2026 Remepy has announced positive results from its Phase IIa clinical trial evaluating Hybridopa™,...

VANCOUVER, British Columbia, May 20, 2026 Optimi Health Corp. has announced the pricing of an oversubscribed US$15 million underwritten...

BOSTON, Mass., May 20, 2026 The Paragon Institute has released a new scientific proposal highlighting the growing risks associated...